MyFinsight
Home
Blog
About
Cash and cash
equivalents
$3,515K
(-60.26%↓ Y/Y)
Research and development
supplies and other...
$1,807K
Prepaid expenses
$528K
(-60.39%↓ Y/Y)
Total property and
equipment at cost
$1,290K
(0.47%↑ Y/Y)
Total current assets
$5,850K
(-42.52%↓ Y/Y)
Operating lease
right-of-use asset, net
$1,321K
(-51.33%↓ Y/Y)
Property and equipment,
net
$710K
(-26.58%↓ Y/Y)
Other assets
$48K
(0.00%↑ Y/Y)
Less accumulated
depreciation
$580K
(82.97%↑ Y/Y)
Total assets
$7,929K
(-42.99%↓ Y/Y)
Total liabilities and
stockholders equity
$7,929K
(-42.99%↓ Y/Y)
Total stockholders
equity
$4,636K
(439.07%↑ Y/Y)
Total liabilities
$3,293K
(-74.76%↓ Y/Y)
Accumulated deficit
-$63,281K
(-40.18%↓ Y/Y)
Additional paid-in capital
$67,916K
(47.64%↑ Y/Y)
Total current
liabilities
$2,213K
(-79.82%↓ Y/Y)
Operating lease
liability, long-term
$1,080K
(-48.15%↓ Y/Y)
Voting common stock,
0.00001 par value...
$1K
Accounts payable and
accrued expenses
$1,821K
(1.11%↑ Y/Y)
Operating lease
liability, short-term
$258K
(-58.85%↓ Y/Y)
Loan payable
$124K
Sepa put option
liability
$10K
(-97.87%↓ Y/Y)
Back
Back
Balance Sheet
FibroBiologics, Inc. (FBLG)
FibroBiologics, Inc. (FBLG)
source: myfinsight.com